This bill, titled the "Stem Cell Therapeutic and Research Reauthorization Act of 2025," aims to extend the provisions of the original Stem Cell Therapeutic and Research Act of 2005, ensuring the continued operation and funding of critical stem cell-related programs. It reauthorizes the C.W. Bill Young Cell Transplantation Program , appropriating $33,009,000 annually for each of fiscal years 2027 through 2031 to maintain its financial stability. Additionally, the legislation extends the duration of the cord blood inventory program , which supports the collection and storage of cord blood units for therapeutic use, until fiscal year 2031 . This extension from its previous expiration in 2026 ensures the ongoing availability of vital resources for stem cell transplantation and research.